Provided by Tiger Trade Technology Pte. Ltd.

CARSGEN-B

17.250
-0.170-0.98%
Volume:3.74M
Turnover:65.00M
Market Cap:9.83B
PE:-85.62
High:18.200
Open:17.780
Low:17.100
Close:17.420
52wk High:25.600
52wk Low:9.900
Shares:570.00M
HK Float Shares:570.00M
Volume Ratio:0.61
T/O Rate:0.66%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.201
ROE:-11.21%
ROA:-9.61%
PB:11.04
PE(LYR):-85.62
PS:68.84

Loading ...

CARsgen Therapeutics (02171) Announces Updates on Share Repurchases and Issued Shares

Bulletin Express
·
Jan 23

CARsgen Therapeutics (02171) Updates Share Repurchase Details and Changes in Issued Shares

Bulletin Express
·
Jan 23

CARSGEN-B Surges Over 4% in Morning Session Following Recent Collaboration Announcement with Dispatch Bio

Deep News
·
Jan 22

HK Stock Movement | CARSGEN-B (02171) Rises Nearly 4%, Recently Announced Collaboration with Dispatch Bio to Plan Related Clinical Trials for CT053

Stock News
·
Jan 22

Will Dispatch Bio CAR T Solid Tumor Trial Shift CARsgen Therapeutics' (SEHK:2171) Narrative?

Simply Wall St.
·
Jan 14

CARsgen Therapeutics Holdings Ltd: Clinical Collaboration to Conduct a Phase 1 Trial in China, Planned to Begin in 2026

THOMSON REUTERS
·
Jan 12

CARsgen Therapeutics and Dispatch Bio launch clinical collaboration on solid tumor therapy

Reuters
·
Jan 12

CARsgen and Dispatch Bio Announce Clinical Collaboration to Evaluate Flare Platform and Zevor-Cel in Solid Tumors

THOMSON REUTERS
·
Jan 12

CARsgen-B (02171) Rises Nearly 6% on Inclusion of Solid Tumor Cell Therapy Project in National Major Scientific Project

Stock News
·
Jan 05

CARSGEN-B (02171) Repurchases 326,000 Shares for HK$4.8477 Million on December 29

Stock News
·
Dec 29, 2025

CARsgen Therapeutics Repurchases 326,000 Shares for HKD 4.85 Million, Files Disclosure with HKEX

Reuters
·
Dec 29, 2025

CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Therapy CT0596

Reuters
·
Dec 29, 2025

Non-Executive Director Guo Huaqing Increases Stake in CARSGEN-B (02171) by 30,000 Shares at HK$15.09 Per Share

Stock News
·
Dec 24, 2025

HK Stock Buyback Summary | Dec 24

Stock News
·
Dec 24, 2025

CARSGEN-B (02171) Repurchased 320,000 Shares for HK$4.8609 Million on December 23

Stock News
·
Dec 23, 2025

CARsgen Therapeutics Repurchases 320,000 Shares for HKD 4.86 Million in HKEX Filing

Reuters
·
Dec 23, 2025

Non-Executive Director Guo Huaqing Increases Stake in CARSGEN-B (02171) by 18,000 Shares at HK$14.52 per Share

Stock News
·
Dec 22, 2025

Is BCMA CAR-T Catalogue Inclusion And Pipeline Progress Altering The Investment Case For CARsgen (SEHK:2171)?

Simply Wall St.
·
Dec 20, 2025

CARsgen Therapeutics Holdings (SEHK:2171): Valuation Check After Zevor‑cel Listing and New CT0596 Data

Simply Wall St.
·
Dec 19, 2025

CARsgen Therapeutics Extends Share Repurchase Program

MT Newswires Live
·
Dec 19, 2025